SAFE HEALTH SYSTEMS INC.

Safe Health Systems, Inc. (“SAFE Health”) is a Digital Healthcare company operated in partnership with Mayo Clinic (“Mayo”). The Company’s mission is to reduce the cost of routine care at population scale, and capture a share of the $2 trillion of global healthcare spend inevitably transitioning to digital delivery in this decade. Through this strategic partnership with SAFE, Mayo Clinic is committed to applying its accumulated knowledge, world-class clinical expertise, and general s... tandard of excellence to empowering billions of patients worldwide with access to quality routine care. Core to realizing its mission is the Company’s Digital Health and Connected Diagnostics Platform that enables rapid implementation of specialized digital healthcare applications designed to improve access to affordable treatment of common medical conditions, efficient chronic disease management, and auditable remote patient monitoring (the “Platform”). Designed by the former Chief Architect of the CDC, the Platform combines virtualized provider services, AI-enabled care automation, electronic patient record interoperability, public health reporting, and remote point-of-care diagnostics to enable companies and world governments to improve healthcare outcomes and reduce delivery costs at population scale. Building on exclusive technology licenses from Columbia University, the Company has developed an integrated Connected Diagnostics System (“CDS”), which completes the connected care loop by enabling self-collection and real-time digital assessment of rapid diagnostic tests outside of the point of care, coupled with a proprietary system for enabling crowdsourced telehealth provider services at the speed and scale required for population-scale adoption. The CDS dramatically extends current telehealth capabilities and will enable a wide range of new remote patient care/monitoring applications.SAFE is currently implementing an IRB study in collaboration with Mayo Clinic and Arizona State University (“ASU”) designed with guidance from the FDA to secure EUA clearance for home (outside lab) use of multiple LFIA-platform COVID-19 rapid antigen and antibody tests.More